QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 joint-q3-eps-006-beats-005-estimate-sales-13381m-beat-13360m-estimate

Joint (NASDAQ:JYNT) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 25 per...

 b-riley-securities-maintains-buy-on-joint-lowers-price-target-to-18

B. Riley Securities analyst Jeff Van Sinderen maintains Joint (NASDAQ:JYNT) with a Buy and lowers the price target from $20 ...

 joint-corp-says-it-expects-to-restate-fy24-and-q1-2025-financial-statements-due-to-overestimated-noncash-impairment-charges

- SEC Filing 

 the-joint-sells-31-clinics-for-83m-gains-control-of-profitable-northwest-franchise-region

The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network...

 the-joint-sells-31-clinics-to-largest-franchisee-expands-northwest-territory-ahead-of-june-30-deal-close

The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network...

 the-joint-corp-approves-5m-stock-buyback-program-starting-august-2025

The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, ...

 lake-street-maintains-buy-on-joint-lowers-price-target-to-16

Lake Street analyst Ryan Meyers maintains Joint (NASDAQ:JYNT) with a Buy and lowers the price target from $20 to $16.

 joint-q1-eps-005-beats-001-estimate-sales-1308m-beat-1302m-estimate

Joint (NASDAQ:JYNT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.01 by 400 pe...

 the-joint-corp-sees-fy25-system-wide-sales-550m-570m

2025 GuidanceThe company provided the following guidance for 2025.System-wide sales are expected to be between $550 million and...

 joint-q4-eps-018-misses-001-estimate-sales-1445m-miss-2899m-estimate

Joint (NASDAQ:JYNT) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $0.01 by 1900...

 the-joint-corp-performed-147m-patient-visits-in-2024-compared-to-136m-in-2023

2024 Full Year Operating HighlightsPerformed 14.7 million patient visits, compared to 13.6 million in 2023.Treated 957,000 new ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION